Five things for pharma marketers to know: Wednesday, October 18, 2017

Share this content:

1. About 60% of doctors say they have received racist, sexist, and other critical remarks from patients, according to a survey fielded by WebMD and Medscape with Stat. At least 14% of doctors say patients put those remarks down on paper. (Stat)

2. Anthem plans to launch a new pharmacy benefit manager, IngenioRx, with CVS Health in 2020. Anthem's contract with Express Scripts ends in 2019. (Forbes)

3. Drugmakers often use excess medication in single-use drugs like eye drops and cancer drugs. The extra medication in each dose is usually wasted. (ProPublica)

4. The FDA granted priority review to AstraZeneca's ovarian cancer drug Lynparza. It is being tested as a treatment for breast cancer and in treatment for prostate and pancreatic cancers. (Reuters)  

5. Researchers are testing artificial intelligence as a means of predicting whether breast lesions will turn cancerous. It identified 335 lesions and correctly diagnosed 97% as malignant. (BBC)

Share this content:
Scroll down to see the next article